These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35456768)

  • 1. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain.
    Vázquez R; Díez-Martínez R; Domingo-Calap P; García P; Gutiérrez D; Muniesa M; Ruiz-Ruigómez M; Sanjuán R; Tomás M; Tormo-Mas MÁ; García P
    Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "FAGOMA: Spanish Network of Bacteriophages and Transducer Elements"-V Meeting Report.
    Redrejo-Rodríguez M; García P
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30567291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as Alternatives to Antibiotics in Clinical Care.
    Romero-Calle D; Guimarães Benevides R; Góes-Neto A; Billington C
    Antibiotics (Basel); 2019 Sep; 8(3):. PubMed ID: 31487893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
    Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating bacterial infections with bacteriophages in the 21st century.
    Opperman CJ; Wojno JM; Brink AJ
    S Afr J Infect Dis; 2022; 37(1):346. PubMed ID: 35399556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges and future opportunities of phage therapy.
    Pires DP; Costa AR; Pinto G; Meneses L; Azeredo J
    FEMS Microbiol Rev; 2020 Nov; 44(6):684-700. PubMed ID: 32472938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages and phage-derived proteins--application approaches.
    Drulis-Kawa Z; Majkowska-Skrobek G; Maciejewska B
    Curr Med Chem; 2015; 22(14):1757-73. PubMed ID: 25666799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
    Hesse S; Adhya S
    Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency.
    Liu C; Hong Q; Chang RYK; Kwok PCL; Chan HK
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulations of phage therapy across the world.
    Yang Q; Le S; Zhu T; Wu N
    Front Microbiol; 2023; 14():1250848. PubMed ID: 37869667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.